Synthesis method of litexitinib tosylate

Through the 4-step reaction synthesis method, litxitinib toluenesulfonate is efficiently synthesized by using intramolecular ring formation and ω-aminotransamination powder, which solves the problems of cumbersome steps and low yields in the existing technology, and achieves economical Efficient production.

CN119060058AInactive Publication Date: 2024-12-03WUHAN JIUZHOU YUMIN PHARM TECH CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411152269.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing synthesis method of litxitinib toluenesulfonate is complicated, with low yield and high cost, which cannot meet the needs of large-scale production.

Method used

The target compound was synthesized with high yield by using easy-to-recover raw materials and simple operations by intramolecular ring formation, imidation amidation, ω-transaminase powder and amino substitution reactions.

Benefits of technology

The synthesis steps are shortened, the yield is improved, the chiral column splitting is avoided, the cost is reduced, and it is suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005003970110000011
    Figure BDA0005003970110000011
  • Figure BDA0005003970110000021
    Figure BDA0005003970110000021
  • Figure BDA0005003970110000071
    Figure BDA0005003970110000071
Patent Text Reader

Abstract

The invention relates to a synthesis method of litexitinib tosylate. The method comprises the following steps: carrying out intramolecular cyclization on raw materials; amidation of an imino group; the alpha, omega-transaminase powder is used for selectively converting carbonyl into required chiral amino with high yield; performing amino substitution reaction; and adding p-methanesulfonic acid for salifying to obtain the target compound, namely the litexitinib tosylate. The designed synthesis reaction route step is short, one chiral enantiomer raw material is used for synthesis, and two times of chiral chromatographic column resolution in a method in the prior art are avoided. In addition, the required chiral amino group is selectively generated with high yield by utilizing the omega-transaminase powder, and the synthesis method has good economical efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biomedicine, and in particular to a method for synthesizing rituximab tosylate. Background Art

[0002] Ritlecitinib Tosylate is a new oral targeted Janus kinase 3 (JAK3) inhibitor that can effectively block the activity of signaling molecules and immune cells, which are believed to be the cause of alopecia areata. On June 23, 2023, Pfizer announced that the U.S. FDA approved the marketing of the innovative drug Ritlecitinib Tosylate Capsules (trade name: LITFULO) for the treatment of severe alopecia areata in people aged 12 years and above. In the field of alopecia areata treatment, this is the second targeted immunosuppressant approved by the FDA and the only treatment for adolescents with severe alopecia areata. On October 19, 2023, the official website of China CDE announced that it approved the marketing of the Class 1 innovative drug Ritlecitinib Tosylate Capsules (trade name: Lefuno) declared by Pfizer, which is suitable for adolescents aged 12 years and above and adults with severe alopecia areata.

[0003] The chemical name of rituximab tosylate is: 1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one 4-methylbenzene-1-sulfonic acid, and the chemical structure is shown in Formula I:

[0004]

[0005] However, the current synthetic methods for rituximab tosylate still need to be improved. Summary of the invention

[0006] The present invention aims to solve at least one of the technical problems in the related art to a certain extent. To this end, one object of the present invention is to propose a method for synthesizing the compound rituximab tosylate shown in formula I. Compared with the prior art, the steps of this route are shortened to 4 steps. The raw materials of the method of the present invention undergo intramolecular cyclization; amidation of the imino group; ω-transaminase powder, high yield and selectivity to convert the carbonyl group into the desired chiral amino group; amino substitution reaction; and addition of p-toluenesulfonic acid to form a salt to obtain the target compound rituximab tosylate.

[0007] In one aspect of the present invention, the present invention provides a method for synthesizing rituximab tosylate, a compound represented by formula I. According to an embodiment of the present invention, the synthesis method comprises:

[0008] (1) contacting the compound represented by Formula 1 with triethylamine, DIPEA, and the compound represented by Formula 2 to obtain the compound represented by Formula 3;

[0009] (2) contacting isopropylamine hydrochloride, triethanolamine hydrochloride, ω-transaminase powder, and pyridoxal phosphate with the compound of Formula 3 to obtain the compound of Formula 4;

[0010] (3) contacting the compound represented by Formula 4 with the compound represented by Formula 5 and an organic base B to obtain a compound represented by Formula 6; (4) contacting the compound represented by Formula 6 with p-toluenesulfonic acid to obtain a compound represented by Formula I, i.e., rituximab tosylate.

[0011] The inventors have found that, using the synthesis method of the present invention, with the compound represented by Formula 1 and the compound represented by Formula 2 as starting materials, a total of 4 steps of reaction can be performed to successfully synthesize and prepare the target product, rituximab tosylate.

[0012] The term "contact" as used herein should be understood in a broad sense, and can be any manner that allows at least two reactants to undergo a chemical reaction, such as mixing the two reactants under appropriate conditions. If necessary, the reactants to be contacted can be mixed under stirring, and thus, the type of stirring is not particularly limited, and can be mechanical stirring, i.e. stirring under the action of mechanical force.

[0013] In this document, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0014] According to an embodiment of the present invention, the method for preparing the compound represented by Formula 3, the compound represented by Formula 4, the compound represented by Formula 6, and the compound represented by Formula I may also have at least one of the following additional technical features:

[0015] According to an embodiment of the present invention, the chemical reaction described in the present invention can be carried out according to any method known in the art. The source of the raw materials of the compound shown in Formula 3, the compound shown in Formula 4, the compound shown in Formula 6, and the compound shown in Formula I is not particularly limited, and they can be prepared by any known method or commercially available.

[0016] According to an embodiment of the present invention, in step (1), the contacting method of the compound represented by Formula 1 with triethylamine, DIPEA, and the compound represented by Formula 2 is not particularly limited. Thus, the efficiency of the contact reaction between the compound represented by Formula 1 and triethylamine, DIPEA, and the compound represented by Formula 2 can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula 3 using this method can be further improved.

[0017] According to an embodiment of the present invention, in step (1), the following steps are included: at room temperature, the compound of formula 1 and triethylamine are added to acetonitrile and stirred, the temperature is slowly raised to 70°C for reaction for 10 hours, TLC monitors the complete reaction of the compound of formula 1, and after the reaction is completed, no post-treatment is required, the reaction solution is cooled, DIPEA is added at 0°C, and then the compound of formula 2 (acryloyl chloride) is slowly added dropwise, the reaction solution is heated to 50°C to 60°C for reaction for 5 to 7 hours, H2O is added for quenching, ethyl acetate is added for extraction 3 times, the organic phases are combined and washed with saturated brine, dried over anhydrous sodium sulfate, and the organic phases are concentrated under reduced pressure, and the concentrate is purified by silica gel column chromatography with a petroleum ether / ethyl acetate mixed solvent to obtain the compound of formula 3. Thus, the efficiency of the contact reaction between the compound of formula 1 and triethylamine, DIPEA, and the compound of formula 2 can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound of formula 3 by using this method can be further improved.

[0018] According to an embodiment of the present invention, in step (1), the molar ratio of the compound represented by Formula 1 to triethylamine, DIPEA, and the compound represented by Formula 2 is 1:1.2:(1.1-1.3):(1.05-1.5), and preferably the molar ratio of the compound represented by Formula 1 to triethylamine, DIPEA, and the compound represented by Formula 2 is 1:1.2:1.2:1.2. Thus, the efficiency of preparing the compound represented by Formula 3 by using this method can be further improved.

[0019] According to an embodiment of the present invention, in step (1), the reaction solution is preferably heated to 55° C. and reacted for 6 hours. Thus, the efficiency of preparing the compound represented by formula 3 by this method can be further improved.

[0020] According to an embodiment of the present invention, in step (1), the volume ratio of the petroleum ether / ethyl acetate mixed solvent is 1:(6-10), preferably the volume ratio of the petroleum ether / ethyl acetate mixed solvent is 1:8.

[0021] According to a specific embodiment of the present invention, in step (1), the following steps are included: at room temperature, the compound represented by formula 1 (6.0 g, 40 mmol) and triethylamine (6.06 g, 48 mmol) are added to acetonitrile (30 mL) and stirred, and the temperature is slowly raised to 70° C. for reaction for 10 hours. TLC monitors the complete reaction of the compound represented by formula 1. After the reaction is completed, no post-treatment is required. After the reaction liquid is cooled, DIPEA (6.20 g, 48 mmol) is added at 0° C., and then the compound represented by formula 2 is slowly added dropwise The compound (acryloyl chloride) (4.35 g, 48 mmol) was prepared. The reaction solution was heated to 55°C for 6 hours, then H2O (20 mL) was added to quench the reaction, and ethyl acetate was added for extraction 3 times (20 ml each time). The organic phases were combined and washed with 40 ml of saturated brine, and dried over anhydrous sodium sulfate. The organic phase was concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography using a mixed solvent of petroleum ether / ethyl acetate in a volume ratio of 1:8 to obtain the compound shown in Formula 3. The yield was 4.89 g, and the total yield was 73.1%.

[0022] According to an embodiment of the present invention, in step (2), the contacting method of isopropylamine hydrochloride, triethanolamine hydrochloride, ω-transaminase powder, pyridoxal phosphate and the compound shown in Formula 3 is not particularly limited. Thus, the efficiency of the contact reaction between isopropylamine hydrochloride, triethanolamine hydrochloride, ω-transaminase powder, pyridoxal phosphate and the compound shown in Formula 3 can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula 4 by using this method can be further improved.

[0023] According to an embodiment of the present invention, in step (2), the following steps are included: at room temperature, 4M isopropylamine hydrochloride and 0.1M triethanolamine hydrochloride are added to the reaction bottle successively, and while the mixed solution is stirred, ω-transaminase powder, pyridoxal phosphate (PLP) and DMSO are added, the reaction solution is heated to about 45°C, and then a solution of the compound shown in Formula 3 dissolved in ethanol is added dropwise, the pH is controlled to be 9.0-11.0, and the reaction is kept at 42°C-60°C for 9-11 hours. After the reaction is completed, the reaction solution is cooled to room temperature, and the reaction solution is filtered with diatomaceous earth to obtain a filtrate, ethyl acetate is added to dissolve, saturated brine is added to wash, the organic phase is dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a concentrate, which is the compound shown in Formula 4. Thus, the efficiency of contacting and reacting isopropylamine hydrochloride, triethanolamine hydrochloride, ω-transaminase powder, pyridoxal phosphate with the compound shown in Formula 3 can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula 4 using this method can be further improved.

[0024] According to an embodiment of the present invention, in step (2), the weight ratio of ω-aminotransferase powder, pyridoxal phosphate and the compound shown in Formula 3 is (0.3-0.5):(0.02-0.03):1, and preferably the weight ratio of ω-aminotransferase powder, pyridoxal phosphate and the compound shown in Formula 3 is 0.36:0.024:1. Thus, the efficiency of preparing the compound shown in Formula 4 by this method can be further improved.

[0025] According to an embodiment of the present invention, in step (2), the weight volume ratio of the compound of formula 3 to 4M isopropylamine hydrochloride is 1:3.6 (g / v), and the weight volume ratio of the compound of formula 3 to 0.1M triethanolamine hydrochloride is 1:2.4 (g / v). Thus, the efficiency of preparing the compound of formula 4 by this method can be further improved.

[0026] According to an embodiment of the present invention, in step (2), the pH is preferably controlled to be 9.5-10.5, and the reaction is kept at 50° C.-55° C. for 10 hours. Thus, the efficiency of preparing the compound represented by Formula 4 by this method can be further improved.

[0027] According to a specific embodiment of the present invention, in step (2), the following steps are included: at room temperature, 4M isopropylamine hydrochloride (15mL) and 0.1M triethanolamine hydrochloride (10mL) are added successively to a reaction bottle, while the mixed solution is stirred, ω-aminotransferase powder (1.5g), pyridoxal phosphate (PLP, 0.1g) and DMSO (15ml) are added, the reaction solution is heated to about 45°C, and a solution of the compound of formula 3 (4.18g, 25.0mmol) dissolved in ethanol (10ml) is added dropwise, the pH is controlled to be 9.5-10.5, and the reaction is kept at 50-55°C for 10 hours. After the reaction is completed, the reaction solution is cooled to room temperature, and the reaction solution is filtered through diatomaceous earth to obtain a filtrate, ethyl acetate (20ml) is added to dissolve, 30ml of saturated brine is added to wash, the organic phase is dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a concentrate, i.e., the compound of formula 4, with an amount of 3.73g and a yield of 88.7%.

[0028] According to an embodiment of the present invention, in step (3), the contacting method of the compound represented by Formula 4, the compound represented by Formula 5, and the organic base B is not particularly limited. Thus, the efficiency of the contact reaction between the compound represented by Formula 4, the compound represented by Formula 5, and the organic base B can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula 6 by using this method can be further improved.

[0029] According to an embodiment of the present invention, in step (3), the following steps are included: at room temperature, n-butanol is added to a reaction flask, and then the compound shown in formula 4, the compound shown in formula 5 and the organic base B are added in sequence, the temperature is slowly raised to reflux under stirring, and the temperature is maintained at reflux for 9-11 hours. The reaction of the compound shown in formula 4 is completely monitored by TLC. After the reaction is completed, the reaction solution naturally drops to room temperature, ethyl acetate and water are added, and the liquid is separated after stirring. The organic phase is added to saturated brine for washing, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound shown in formula 6. The crude product is placed in a reaction flask, ethyl acetate and n-hexane are added, and the temperature is raised to 60°C for pulping and purification for 1 hour. After naturally dropping to room temperature, the solid is decompressed and filtered to obtain a solid refined product of the compound shown in formula 6. Thus, the efficiency of the contact reaction between the compound shown in formula 4 and the compound shown in formula 5 and DIPEA can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in formula 6 by this method can be further improved.

[0030] According to an embodiment of the present invention, in step (3), the molar ratio of the compound represented by Formula 4 to the compound represented by Formula 5 and the organic base B is 1:(1.0-1.2):(2.5-4), and preferably the molar ratio of the compound represented by Formula 4 to the compound represented by Formula 5 and the organic base B is 1:1.05:3. Thus, the efficiency of preparing the compound represented by Formula 6 by this method can be further improved.

[0031] According to an embodiment of the present invention, in step (3), the organic base B is at least one selected from DIPEA, ethylenediamine or triethylamine.

[0032] According to an embodiment of the present invention, in step (3), the stirring time in the reflux state is preferably maintained for 10 hours.

[0033] According to a specific embodiment of the present invention, in step (3), the following steps are included: at room temperature, n-butanol (30 mL) is added to a reaction bottle, and then the compound represented by formula 4 (2.70 g, 16 mmol), the compound represented by formula 5 (2.58 g, 16.8 mmol) and DIPEA (6.20 g, 48 mmol) are added in sequence, the temperature is slowly raised to reflux under stirring, and the stirring is maintained at reflux for 10 hours. TLC monitors that the reaction of the compound represented by formula 4 is complete. After the reaction is completed, the reaction solution is naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) are added, stirred and separated, the organic phase is washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by formula 6. The crude product is placed in a reaction bottle, ethyl acetate (70 mL) and n-hexane (210 mL) are added, the temperature is raised to 60°C for pulping and purification for 1 hour, and after naturally cooling to room temperature, the solid is filtered under reduced pressure to obtain a solid refined product of the compound represented by formula 6, with an amount of 3.53 g and a yield of 77.3%.

[0034] According to an embodiment of the present invention, in step (4), the contacting method of the compound represented by Formula 6 with p-toluenesulfonic acid is not particularly limited. Thus, the efficiency of the contacting reaction of the compound represented by Formula 6 with p-toluenesulfonic acid can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula I by using this method can be further improved.

[0035] According to an embodiment of the present invention, in step (4), the following steps are included: at room temperature, dissolving the compound shown in Formula 6 in an organic solvent C, slowly dropping p-toluenesulfonic acid, maintaining stirring at room temperature for 1 hour, precipitating a large amount of solids, filtering the solids, washing the filter cake with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallizing with methanol, and vacuum drying the filtered filter cake to obtain the compound shown in Formula I, rituximab tosylate. Thus, the efficiency of the contact reaction between the compound shown in Formula 6 and p-toluenesulfonic acid can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula I, rituximab tosylate, by using this method can be further improved.

[0036] According to an embodiment of the present invention, in step (4), the molar ratio of the compound represented by Formula 6 to p-toluenesulfonic acid is 1:(1.05-1.2), preferably the molar ratio of the compound represented by Formula 6 to p-toluenesulfonic acid is 1:1.1. Thus, the efficiency of preparing the compound represented by Formula I by this method can be further improved.

[0037] According to an embodiment of the present invention, in step (4), the organic solvent C is at least one selected from ethanol, acetone, or tetrahydrofuran.

[0038] According to a specific embodiment of the present invention, in step (4), the following steps are included: at room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) is dissolved in 30 mL of ethanol, p-toluenesulfonic acid (1.93 g, 11.20 mmol) is slowly added dropwise, and the mixture is stirred at room temperature for 1 hour to precipitate a large amount of solid, the solid is filtered, the filter cake is washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake is vacuum dried to obtain the compound represented by formula I, i.e., 3.96 g, with a yield of 85.2% and a HPLC purity of 99.8%.

[0039] According to a specific embodiment of the present invention, the synthetic route of the compound of formula I, rituximab tosylate, can be as follows:

[0040]

[0041] Compared with the prior art, the synthesis method of rituximab tosylate described in the present invention has at least the following beneficial effects:

[0042] 1. The raw materials of the method described in the present invention undergo intramolecular cyclization; amidation of the imino group; ω-transaminase powder, high yield and selectivity to convert the carbonyl group into the desired chiral amino group; amino substitution reaction; and addition of p-toluenesulfonic acid to form a salt to obtain the target compound, rituximab tosylate.

[0043] 2. Compared with the prior art methods, the present invention has the following significant advantages: (1) In the prior art, 5-methyl-3-aminopyridine is used as a raw material, and the use of a metal rhodium catalyst to reduce the pyridine ring to a piperidine ring is disclosed; or the use of PtO2 as a catalyst to reduce the pyridine ring is disclosed. However, metal catalysts are expensive, and generally use hydrogen for reduction, and the hydrogenation is carried out under high pressure and for a long time, and the reaction conditions are harsh. For example, platinum black generated by using PtO2 is flammable and dangerous to produce. The raw materials used in the present invention are easy to obtain, and no reduction step is required. The operation method is simple and the product yield is high. (2) The synthesis route steps introduced in the prior art are redundant. Long, twice Chiral chromatography column separation not only has low yield and high cost, but also cannot be scaled up. The route is short and uses a chiral enantiomer as a raw material for synthesis, avoiding the two chiral chromatographic column separations in the prior art method. (3) ω-aminotransferase powder is used to generate the required chiral amino group with high yield and selectivity, and the synthetic route has good economic efficiency. (4) The present invention adopts a one-pot method to react the compound shown in Formula 1 with triethylamine in acetonitrile by heating to generate an intermediate compound The reaction to generate the compound does not require post-treatment, and can continue to start the following reaction with DIPEA and acryloyl chloride. The two-step reaction is combined into a one-step one-pot method, which shortens the number of reaction steps; at the same time, the post-treatment is simple and easy, and the intermediate product only needs to be refined by column chromatography, which is suitable for large-scale production. (5) The raw materials selected in the present invention are easy to obtain, the operation method is simple, and the product yield is high. DETAILED DESCRIPTION

[0044] The embodiments of the present invention are described in detail below. The embodiments described below are exemplary and are only used to explain the present invention, and should not be construed as limiting the present invention. If no specific techniques or conditions are specified in the embodiments, the techniques or conditions described in the literature in this area or the product specifications are used. The reagents or instruments used that do not specify the manufacturer are all conventional products that can be obtained commercially.

[0045] Example 1 Synthesis of the compound represented by formula 3

[0046] At room temperature, the compound represented by formula 1 (6.0 g, 40 mmol) and triethylamine (6.06 g, 48 mmol) were added to acetonitrile (30 mL) with stirring, and the temperature was slowly raised to 70°C for reaction for 10 hours. The compound represented by formula 1 was completely reacted by TLC monitoring. After the reaction was completed, no post-treatment was required. After the reaction solution was cooled, DIPEA (6.20 g, 48 mmol) was added at 0°C, and then the compound represented by formula 2 (acryloyl chloride) (4.35 g, 48 mmol) was slowly added dropwise. After the reaction solution was heated to 55°C for 6 hours, H2O (20 mL) was added for quenching, and ethyl acetate was added for extraction 3 times (20 ml each time). After the organic phases were combined, 40 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. After the organic phases were concentrated under reduced pressure, the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 1:8 to obtain the compound represented by formula 3, with an amount of 4.89 g and a total yield of 73.1%.

[0047] LC-MS (APCI): m / z = 168.3 (M+1) + .

[0048] Example 2 Synthesis of the compound represented by formula 3

[0049] At room temperature, the compound represented by formula 1 (6.0 g, 40 mmol) and triethylamine (6.06 g, 48 mmol) were added to acetonitrile (30 mL) with stirring, and the temperature was slowly raised to 70°C for reaction for 10 hours. The compound represented by formula 1 was completely reacted as monitored by TLC. After the reaction was completed, no post-treatment was required. After the reaction solution was cooled, DIPEA (5.68 g, 44 mmol) was added at 0°C, and then the compound represented by formula 2 (acryloyl chloride) (3.80 g, 42 mmol) was slowly added dropwise. After the reaction solution was heated to 50°C for reaction for 7 hours, H2O (20 mL) was added for quenching, and ethyl acetate was added for extraction 3 times (20 ml each time). After the organic phases were combined, 40 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. After the organic phases were concentrated under reduced pressure, the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 1:6 to obtain the compound represented by formula 3, with an amount of 4.69 g and a total yield of 70.1%.

[0050] Example 3 Synthesis of the compound represented by formula 3

[0051] At room temperature, the compound represented by formula 1 (6.0 g, 40 mmol) and triethylamine (6.06 g, 48 mmol) were added to acetonitrile (30 mL) with stirring, and the temperature was slowly raised to 70°C for reaction for 10 hours. The compound represented by formula 1 was completely reacted by TLC monitoring. After the reaction was completed, no post-treatment was required. After the reaction solution was cooled, DIPEA (8.06 g, 52 mmol) was added at 0°C, and then the compound represented by formula 2 (acryloyl chloride) (5.43 g, 60 mmol) was slowly added dropwise. After the reaction solution was heated to 60°C for reaction for 5 hours, H2O (20 mL) was added to quench, and ethyl acetate was added for extraction 3 times (20 ml each time). After the organic phases were combined, 40 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. After the organic phases were concentrated under reduced pressure, the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 1:10 to obtain the compound represented by formula 3, with an amount of 4.80 g and a total yield of 71.8%.

[0052] Comparative Example 1: Synthesis of the compound represented by Formula 3

[0053] At room temperature, the compound represented by formula 1 (6.0 g, 40 mmol) and triethylamine (6.06 g, 48 mmol) were added to acetonitrile (30 mL) with stirring, and the temperature was slowly raised to 70°C for reaction for 10 hours. The compound represented by formula 1 was completely reacted by TLC monitoring. After the reaction was completed, no post-treatment was required. After the reaction solution was cooled, DIPEA (5.17 g, 40 mmol) was added at 0°C, and then the compound represented by formula 2 (acryloyl chloride) (3.62 g, 40 mmol) was slowly added dropwise. After the reaction solution was heated to 55°C for 6 hours, H2O (20 mL) was added for quenching, and ethyl acetate was added for extraction 3 times (20 ml each time). After the organic phases were combined, 40 ml of saturated brine was added for washing, and the mixture was dried over anhydrous sodium sulfate. After the organic phases were concentrated under reduced pressure, the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 1:4 to obtain the compound represented by formula 3, with an amount of 4.39 g and a total yield of 65.6%.

[0054] Example 4 Synthesis of the compound represented by formula 4

[0055] At room temperature, 4M isopropylamine hydrochloride (15mL) and 0.1M triethanolamine hydrochloride (10mL) were added to the reaction bottle successively. While the mixed solution was stirred, ω-aminotransferase powder (1.5g), pyridoxal phosphate (PLP, 0.1g) and DMSO (15ml) were added. After the reaction solution was heated to about 45°C, a solution of the compound shown in Formula 3 (4.18g, 25.0mmol) dissolved in ethanol (10ml) was added dropwise, and the pH was controlled to be 9.5-10.5. The reaction was kept at 50-55°C for 10 hours. After the reaction was completed, the reaction solution was cooled to room temperature, and the reaction solution was filtered through diatomaceous earth to obtain a filtrate. Ethyl acetate (20ml) was added to dissolve it, and 30ml of saturated brine was added to wash it. The organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain a concentrate, i.e., the compound shown in Formula 4, with an amount of 3.73g and a yield of 88.7%.

[0056] LC-MS (APCI): m / z = 168.3 (M+1) + .

[0057] Example 5 Synthesis of the compound represented by formula 4

[0058] At room temperature, 4M isopropylamine hydrochloride (15mL) and 0.1M triethanolamine hydrochloride (10mL) were added to the reaction flask successively. While the mixed solution was stirred, ω-aminotransferase powder (1.254g), pyridoxal phosphate (0.084g) and DMSO (15ml) were added. After the reaction solution was heated to about 45°C, a solution of the compound shown in Formula 3 (4.18g, 25.0mmol) dissolved in ethanol (10ml) was added dropwise. The pH was controlled to be 9.0-9.5. The reaction was kept at 42°C-50°C for 11 hours. After the reaction was completed, the reaction solution was cooled to room temperature. The reaction solution was filtered through diatomaceous earth to obtain a filtrate. Ethyl acetate (20ml) was added to dissolve it, and 30ml of saturated brine was added to wash it. The organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain a concentrate, i.e., the compound shown in Formula 4, with an amount of 3.61g and a yield of 85.9%.

[0059] Example 6 Synthesis of the compound represented by formula 4

[0060] At room temperature, 4M isopropylamine hydrochloride (15mL) and 0.1M triethanolamine hydrochloride (10mL) were added to the reaction flask successively. While the mixed solution was stirred, ω-aminotransferase powder (2.09g), pyridoxal phosphate (0.125g) and DMSO (15ml) were added. After the reaction solution was heated to about 45°C, a solution of the compound shown in Formula 3 (4.18g, 25.0mmol) dissolved in ethanol (10ml) was added dropwise. The pH was controlled to be 10.5-11.0. The reaction was kept at 55°C-60°C for 9 hours. After the reaction was completed, the reaction solution was cooled to room temperature. The reaction solution was filtered through diatomaceous earth to obtain a filtrate. Ethyl acetate (20ml) was added to dissolve it, and 30ml of saturated brine was added to wash it. The organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain a concentrate, i.e., the compound shown in Formula 4, with an amount of 3.67g and a yield of 87.3%.

[0061] Example 7 Synthesis of the compound represented by formula 6

[0062] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by Formula 4 (2.70 g, 16 mmol), the compound represented by Formula 5 (2.58 g, 16.8 mmol) and DIPEA (6.20 g, 48 mmol) were added in sequence. The temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 10 hours. The reaction of the compound represented by Formula 4 was complete by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) were added, stirred and separated, and the organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by Formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by Formula 6, with an amount of 3.53 g and a yield of 77.3%.

[0063] LC-MS (APCI): m / z=286.3(M+1)+.

[0064] Example 8 Synthesis of the compound represented by formula 6

[0065] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by formula 4 (2.70 g, 16 mmol), the compound represented by formula 5 (2.46 g, 16.0 mmol) and DIPEA (5.17 g, 40 mmol) were added in sequence. The temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 9 hours. The reaction of the compound represented by formula 4 was completed by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) were added, and the mixture was separated after stirring. The organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by formula 6, with an amount of 3.39 g and a yield of 74.2%.

[0066] Example 9 Synthesis of the compound represented by formula 6

[0067] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by Formula 4 (2.70 g, 16 mmol), the compound represented by Formula 5 (2.95 g, 19.2 mmol) and DIPEA (8.27 g, 64 mmol) were added in sequence. The temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 11 hours. The reaction of the compound represented by Formula 4 was complete by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (35 mL) and water (35 mL) were added, stirred and separated, and the organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by Formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by Formula 6, with an amount of 3.49 g and a yield of 76.5%.

[0068] Example 10 Synthesis of the compound represented by formula 6

[0069] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by formula 4 (2.70 g, 16 mmol), the compound represented by formula 5 (2.58 g, 16.8 mmol) and ethylenediamine (2.89 g, 48.1 mmol) were added in sequence, and the temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 10 hours. The reaction of the compound represented by formula 4 was completed by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) were added, and the mixture was separated after stirring. The organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by formula 6, with an amount of 3.41 g and a yield of 74.7%.

[0070] Example 11 Synthesis of the compound represented by formula 6

[0071] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by formula 4 (2.70 g, 16 mmol), the compound represented by formula 5 (2.58 g, 16.8 mmol) and triethylamine (4.86 g, 48 mmol) were added in sequence. The temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 10 hours. The reaction of the compound represented by formula 4 was complete by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) were added, stirred and separated, and the organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by formula 6, with an amount of 3.43 g and a yield of 75.1%.

[0072] Comparative Example 2: Synthesis of the compound represented by Formula 6

[0073] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by Formula 4 (2.70 g, 16 mmol), the compound represented by Formula 5 (2.41 g, 15.7 mmol) and DIPEA (4.13 g, 32 mmol) were added in sequence. The temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 10 hours. The reaction of the compound represented by Formula 4 was basically complete by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) were added, and the mixture was separated after stirring. The organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by Formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by Formula 6, with an amount of 2.91 g and a yield of 63.8%.

[0074] Comparative Example 3: Synthesis of the compound represented by Formula 6

[0075] At room temperature, n-butanol (30 mL) was added to the reaction flask, and then the compound represented by Formula 4 (2.70 g, 16 mmol), the compound represented by Formula 5 (3.19 g, 20.8 mmol) and DIPEA (10.34 g, 80 mmol) were added in sequence. The temperature was slowly raised to reflux under stirring, and the mixture was kept under reflux and stirred for 12 hours. The reaction of the compound represented by Formula 4 was complete by TLC monitoring. After the reaction, the reaction solution naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) were added, stirred and separated, and the organic phase was washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by Formula 6. The crude product was placed in a reaction flask, ethyl acetate (70 mL) and n-hexane (210 mL) were added, and the temperature was raised to 60° C. for pulping and purification for 1 hour. After naturally cooling to room temperature, the solid was filtered under reduced pressure to obtain a solid refined product of the compound represented by Formula 6, with an amount of 3.31 g and a yield of 72.5%.

[0076] Example 12 Synthesis of the compound represented by formula I

[0077] At room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) was dissolved in 30 mL of ethanol, and p-toluenesulfonic acid (1.93 g, 11.20 mmol) was slowly added dropwise, and the mixture was stirred at room temperature for 1 hour. A large amount of solid was precipitated, and the solid was filtered. The filter cake was washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake was vacuum dried to obtain the compound represented by formula I, i.e., 3.96 g, with a yield of 85.2% and a purity of 99.8%.

[0078] LC-MS (APCI): m / z=286.3(M+1)+.

[0079] Example 13 Synthesis of the compound represented by formula I

[0080] At room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) was dissolved in 30 mL of ethanol, and p-toluenesulfonic acid (1.84 g, 10.67 mmol) was slowly added dropwise, and the mixture was stirred at 20-25 ° C for 1 hour. A large amount of solid was precipitated, and the solid was filtered. The filter cake was washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake was vacuum dried to obtain the compound represented by formula I, i.e., 3.81 g, a yield of 81.9%, and a purity of 99.6%.

[0081] Example 14 Synthesis of the compound represented by formula I

[0082] At room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) was dissolved in 30 mL of ethanol, and p-toluenesulfonic acid (2.10 g, 12.19 mmol) was slowly added dropwise, and the temperature was kept at 20-25 ° C. and stirred for 1 hour. A large amount of solid was precipitated. The solid was filtered, and the filter cake was washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake was vacuum dried to obtain the compound represented by formula I, i.e., rituximab tosylate, with an amount of 3.92 g, a yield of 84.3%, and a purity of 99.5%.

[0083] Example 15 Synthesis of the compound represented by formula I

[0084] At room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) was dissolved in 30 mL of acetone, and p-toluenesulfonic acid (1.93 g, 11.20 mmol) was slowly added dropwise, and the temperature was kept at 20-25 ° C. and stirred for 1 hour. A large amount of solid was precipitated. The solid was filtered, and the filter cake was washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake was vacuum dried to obtain the compound represented by formula I, i.e., rituximab tosylate, with an amount of 3.73 g, a yield of 80.2%, and a purity of 99.4%.

[0085] Example 16 Synthesis of the compound represented by formula I

[0086] At room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) was dissolved in 30 mL of tetrahydrofuran, and p-toluenesulfonic acid (1.93 g, 11.20 mmol) was slowly added dropwise, and the mixture was stirred at 20-25 ° C for 1 hour. A large amount of solid was precipitated, and the solid was filtered. The filter cake was washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake was vacuum dried to obtain the compound represented by formula I, i.e., rituximab tosylate, with an amount of 3.67 g, a yield of 81.0%, and a purity of 99.9%.

[0087] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.

[0088] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.

Claims

1. A method for synthesizing rituximab tosylate, characterized in that: include: (1) contacting the compound represented by Formula 1 with triethylamine, DIPEA, and the compound represented by Formula 2 to obtain the compound represented by Formula 3; (2) contacting isopropylamine hydrochloride, triethanolamine hydrochloride, ω-transaminase powder, and pyridoxal phosphate with the compound of Formula 3 to obtain the compound of Formula 4; (3) contacting the compound represented by Formula 4 with the compound represented by Formula 5 and an organic base B to obtain the compound represented by Formula 6; (4) contacting the compound represented by Formula 6 with p-toluenesulfonic acid to obtain the compound represented by Formula I, rituximab tosylate, Wherein, the organic base B is at least one selected from DIPEA, ethylenediamine or triethylamine.

2. The method according to claim 1, characterized in that In step (1), the following steps are included: at room temperature, adding the compound of formula 1 and triethylamine to acetonitrile with stirring, slowly heating to 70°C for reaction for 10 hours, monitoring the complete reaction of the compound of formula 1 by TLC, and after the reaction is completed, no post-treatment is required, cooling the reaction solution, adding DIPEA at 0°C, and then slowly adding dropwise the compound of formula 2, heating the reaction solution to 50°C to 60°C for reaction for 5 to 7 hours, adding H2O for quenching, adding ethyl acetate for extraction 3 times, combining the organic phases, washing with saturated brine, drying over anhydrous sodium sulfate, concentrating the organic phase under reduced pressure, and purifying the concentrate by silica gel column chromatography with a petroleum ether / ethyl acetate mixed solvent to obtain the compound of formula 3.

3. The method according to claim 2, characterized in that In step (1), the molar ratio of the compound represented by formula 1 to triethylamine, DIPEA, and the compound represented by formula 2 is 1:1.2:(1.1-1.3):(1.05-1.5), preferably the molar ratio of the compound represented by formula 1 to triethylamine, DIPEA, and the compound represented by formula 2 is 1:1.2:1.2:1.2; Optionally, in step (1), the reaction solution is preferably heated to 55° C. and reacted for 6 hours; Optionally, in step (1), the volume ratio of the petroleum ether / ethyl acetate mixed solvent is 1:(6-10), preferably the volume ratio of the petroleum ether / ethyl acetate mixed solvent is 1:

8.

4. The method according to claim 1, characterized in that In step (2), the following steps are included: at room temperature, 4M isopropylamine hydrochloride and 0.1M triethanolamine hydrochloride are added to a reaction bottle in sequence; while the mixed solution is stirred, ω-aminotransferase powder, pyridoxal phosphate and DMSO are added; after the reaction solution is heated to about 45° C., a solution of the compound of formula 3 dissolved in ethanol is added dropwise; the pH value is controlled to be 9.0-11.0; the reaction is carried out at 42° C.-60° C. for 9-11 hours; after the reaction is completed, the reaction solution is cooled to room temperature; the reaction solution is filtered through diatomaceous earth to obtain a filtrate; ethyl acetate is added to dissolve the filtrate; saturated brine is added to wash the filtrate; the organic phase is dried over anhydrous sodium sulfate; and the concentrate is concentrated under reduced pressure to obtain a concentrate, which is the compound of formula 4.

5. The method according to claim 4, characterized in that In step (2), the weight ratio of ω-aminotransferase powder, pyridoxal phosphate and the compound represented by formula 3 is (0.3-0.5):(0.02-0.03):1, preferably the weight ratio of ω-aminotransferase powder, pyridoxal phosphate and the compound represented by formula 3 is 0.36:0.024:1; Optionally, in step (2), the weight volume ratio of the compound represented by formula 3 to 4M isopropylamine hydrochloride is 1:3.6 (g / v); Optionally, in step (2), the weight volume ratio of the compound represented by formula 3 to 0.1 M triethanolamine hydrochloride is 1:2.4 (g / v); Optionally, in step (2), the pH is preferably controlled to be 9.5 to 10.5, and the reaction is kept at 50° C. to 55° C. for 10 hours.

6. The method according to claim 1, characterized in that In step (3), the following steps are included: adding n-butanol to a reaction flask at room temperature, and then adding the compound represented by formula 4, the compound represented by formula 5 and the organic base B in sequence, slowly heating to reflux under stirring, maintaining stirring at reflux for 9-11 hours, and monitoring the complete reaction of the compound represented by formula 4 by TLC. After the reaction is completed, the reaction solution is naturally cooled to room temperature, ethyl acetate and water are added, stirred and separated, the organic phase is washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by formula 6. The crude product is placed in a reaction flask, ethyl acetate and n-hexane are added, the temperature is raised to 60°C, and pulping is performed for purification for 1 hour. After the temperature is naturally cooled to room temperature, the solid is filtered under reduced pressure to obtain a solid refined product of the compound represented by formula 6.

7. The method according to claim 6, characterized in that In step (3), the molar ratio of the compound represented by formula 4 to the compound represented by formula 5 and the organic base B is 1:(1.0-1.2):(2.5-4), preferably the molar ratio of the compound represented by formula 4 to the compound represented by formula 5 and the organic base B is 1:1.05:3; Optionally, in step (3), the organic base B is at least one selected from DIPEA, ethylenediamine or triethylamine; Optionally, in step (3), the stirring time under reflux is preferably maintained for 10 hours.

8. The method according to claim 1, characterized in that In step (4), the following steps are included: at room temperature, dissolving the compound represented by formula 6 in an organic solvent C, slowly adding p-toluenesulfonic acid, maintaining stirring at room temperature for 1 hour, precipitating a large amount of solid, filtering the solid, washing the filter cake with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallizing with methanol. The filtered filter cake is vacuum dried to obtain the compound represented by formula I, rituximab tosylate.

9. The method according to claim 8, characterized in that In step (4), the molar ratio of the compound represented by formula 6 to p-toluenesulfonic acid is 1:(1.05-1.2), preferably the molar ratio of the compound represented by formula 6 to p-toluenesulfonic acid is 1:1.1; Optionally, in step (4), the organic solvent C is at least one selected from ethanol, acetone, or tetrahydrofuran.

10. The method according to claim 1, characterized in that In step (1), the following steps are included: at room temperature, adding the compound represented by formula 1 (6.0 g, 40 mmol) and triethylamine (6.06 g, 48 mmol) to acetonitrile (30 mL) and stirring, slowly heating to 70° C. for reaction for 10 hours, monitoring by TLC that the compound represented by formula 1 is completely reacted, and after the reaction is completed, no post-treatment is required. After the reaction is completed, the reaction solution is cooled, DIPEA (6.20 g, 48 mmol) is added at 0° C., and then the compound represented by formula 2 (acryloyl chloride) (4.35 g, 48 mmol) is slowly added dropwise, the reaction solution is heated to 55° C. for reaction for 6 hours, H2O (20 mL) is added to quench, ethyl acetate is added for extraction 3 times (20 ml each time), the organic phases are combined, 40 ml of saturated brine is added for washing, and the organic phases are dried over anhydrous sodium sulfate. After the organic phases are concentrated under reduced pressure, the concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 1:8 to obtain the compound represented by formula 3, with an amount of 4.89 g and a total yield of 73.1%; In step (2), the following steps are included: at room temperature, 4M isopropylamine hydrochloride (15mL) and 0.1M triethanolamine hydrochloride (10mL) are added to a reaction bottle in sequence, while the mixed solution is stirred, ω-aminotransferase powder (1.5g), pyridoxal phosphate (PLP, 0.1g) and DMSO (15ml) are added, the reaction solution is heated to about 45°C, a solution of the compound of formula 3 (4.18g, 25.0mmol) dissolved in ethanol (10ml) is added dropwise, the pH is controlled to be 9.5-10.5, and the reaction is kept at 50-55°C for 10 hours. After the reaction is completed, the reaction solution is cooled to room temperature, the reaction solution is filtered through diatomaceous earth to obtain a filtrate, ethyl acetate (20ml) is added to dissolve, 30ml of saturated brine is added to wash, the organic phase is dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a concentrate, i.e., the compound of formula 4, with an amount of 3.73g and a yield of 88.7%; In step (3), the following steps are included: at room temperature, adding n-butanol (30 mL) to a reaction bottle, and then adding the compound represented by formula 4 (2.70 g, 16 mmol), the compound represented by formula 5 (2.58 g, 16.8 mmol) and DIPEA (6.20 g, 48 mmol) in sequence, slowly heating and refluxing under stirring, maintaining stirring in the reflux state for 10 hours, monitoring the complete reaction of the compound represented by formula 4 by TLC, and after the reaction, the reaction solution is naturally cooled to room temperature, ethyl acetate (30 mL) and water (30 mL) are added, stirred and separated, the organic phase is washed with 40 ml of saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid crude product of the compound represented by formula 6, the crude product is placed in a reaction bottle, ethyl acetate (70 mL) and n-hexane (210 mL) are added, the temperature is raised to 60° C., pulped and purified for 1 hour, and after naturally cooling to room temperature, the solid is filtered under reduced pressure to obtain a solid refined product of the compound represented by formula 6, with an amount of 3.53 g and a yield of 77.3%; In step (4), the following steps are included: at room temperature, the compound represented by formula 6 (2.9 g, 10.16 mmol) is dissolved in 30 mL of ethanol, p-toluenesulfonic acid (1.93 g, 11.20 mmol) is slowly added dropwise, and the mixture is stirred at room temperature for 1 hour to precipitate a large amount of solid, the solid is filtered, the filter cake is washed with an appropriate amount of ethylene glycol dimethyl ether, and then recrystallized with 10 ml of methanol. The filtered filter cake is vacuum dried to obtain the compound represented by formula I, 3.96 g, a yield of 85.2%, and a HPLC purity of 99.8%.

Citation Information

Patent Citations

  • Pyrazolo-quinazolines

    CN102076689A

  • Preparation method of piperidylamine

    CN112824381A

  • Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, pyrrolo[2,3-b]pyridinyl acrylamides and epoxides thereof

    US20190002466A1

  • Enantiomeric enrichment and stereoselective synthesis of chiral amines

    US4950606A